Deep sequencing approaches to antibody discovery

Current Drug Discovery Technologies

Volumn 11, Issue 1, 2014, Pages 85-95

  Naso, Michael F ^a   Lu, Jin ^a   Panavas, Tadas ^a  

^a API Large Molecule Pharmaceutical Development and Manufacturing Sciences   (United States)

Author keywords

Antibody discovery; Biotherapeutic; Deep sequencing; Diversity; Phage display; Rodent immunization

Indexed keywords

ANTIBODY; CD40 LIGAND; INTERLEUKIN 21; TRANSCRIPTOME;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; HELPER CELL; HUMAN; HYBRIDOMA; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; SOMATIC MUTATION;

ANIMALS; ANTIBODIES; DRUG DISCOVERY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS;

EID: 84900851347     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/15701638113106660040     Document Type: Article

References (55)

1. Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 2010; 9(10): 767-74.
2. Reichert JM. Marketed therapeutic antibodies compendium. MAbs 2012; 4(3): 413-5.
3. Reichert JM. Antibody-based therapeutics to watch in 2011. MAbs 2011; 3(1): 76-99.
4. Reichert JM. Which are the antibodies to watch in 2012 MAbs 2012; 4(1): 1-3.
5. Liu L, Li Y, Li S, et al. Comparison of next-generation sequencing systems. J Biomed Biotechnol 2012; 2012: 251364.
6. Metzker ML. Sequencing technologies-The next generation. Nat Rev Genet 2010; 11(1): 31-46.
7. Niedringhaus TP, Milanova D, Kerby MB, Snyder MP, Barron AE. Landscape of next-generation sequencing technologies. Anal Chem 2011; 83(12): 4327-41.
8. Matsuda F, Ishii K, Bourvagnet P, et al. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 1998; 188(11): 2151-62.
9. Glanville J, Zhai W, Berka J, et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc Natl Acad Sci USA 2009; 106(48): 20216-21.
10. Scott MG, Crimmins DL, McCourt DW, et al. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. III. A single VKII gene and one of several JK genes are joined by an invariant arginine to form the most common L chain V region. J Immunol 1989; 143(12): 4110-6.
11. Lefranc MP, Giudicelli V, Ginestoux C, et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 2009; 37(Database issue): D1006-D1012.
12. Dudley DD, Chaudhuri J, Bassing CH, Alt FW. Mechanism and control of V(D)J recombination versus class switch recombination: Similarities and differences. Adv Immunol 2005; 86: 43-112.
13. Rada C, Ehrenstein MR, Neuberger MS, Milstein C. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 1998; 9(1): 135-41.
14. Dorner T, Foster SJ, Farner NL, Lipsky PE. Somatic hypermutation of human immunoglobulin heavy chain genes: Targeting of RGYW motifs on both DNA strands. Eur J Immunol 1998; 28(10): 3384-96.
15. Basalp A, Yucel F. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow. Hybrid Hybridomics 2003; 22(5): 329-31.
16. Milstein C. The hybridoma revolution: An offshoot of basic research. Bioessays 1999; 21(11): 966-73.
17. Pirofski L, Casadevall A, Rodriguez L, Zuckier LS, Scharff MD. Current state of the hybridoma technology. J Clin Immunol 1990; 10(6 Suppl): 5S-12S.
18. Steinitz M. Three decades of human monoclonal antibodies: Past, present and future developments. Hum Antibodies 2009; 18(1-2): 1-10.
19. Lonberg N. Fully human antibodies from transgenic mouse and phage display platforms. Curr Opin Immunol 2008 Aug; 20(4): 450-9.
20. Lonberg N. Human monoclonal antibodies from transgenic mice. Handb Exp Pharmacol 2008; (181): 69-97.
21. Parmley SF, Smith GP. Filamentous fusion phage cloning vectors for the study of epitopes and design of vaccines. Adv Exp Med Biol 1989; 251: 215-8: 215-8.
22. Smith GP. Surface presentation of protein epitopes using bacteriophage expression systems. Curr Opin Biotechnol 1991; 2(5): 668-73.
23. Soderlind E, Simonsson AC, Borrebaeck CA. Phage display technology in antibody engineering: Design of phagemid vectors and in vitro maturation systems. Immunol Rev 1992; 130: 109-24.
24. Hoogenboom HR. Overview of antibody phage-display technology and its applications. Methods Mol Biol 2002; 178: 1-37.
25. Qi H, Lu H, Qiu HJ, Petrenko V, Liu A. Phagemid vectors for phage display: Properties, characteristics and construction. J Mol Biol 2012; 417(3): 129-43.
26. 't Hoen PA, Jirka SM, Ten Broeke BR, et al. Phage display screening without repetitious selection rounds. Anal Biochem 2012; 421(2): 622-31.
27. Benhar I. Design of synthetic antibody libraries. Expert Opin Biol Ther 2007; 7(5): 763-79.
28. Tohidkia MR, Barar J, Asadi F, Omidi Y. Molecular considerations for development of phage antibody libraries. J Drug Target 2012 Apr; 20(3): 195-208.
29. Schirrmann T, Meyer T, Schutte M, Frenzel A, Hust M. Phage display for the generation of antibodies for proteome research, diagnostics and therapy. Molecules 2011; 16(1): 412-26.
30. Ponsel D, Neugebauer J, Ladetzki-Baehs K, Tissot K. High affinity, developability and functional size: The holy grail of combinatorial antibody library generation. Molecules 2011; 16(5): 3675-700.
31. Lanzavecchia A, Corti D, Sallusto F. Human monoclonal antibodies by immortalization of memory B cells. Curr Opin Biotechnol 2007; 18(6): 523-8.
32. Cole SP, Campling BG, Atlaw T, Kozbor D, Roder JC. Human monoclonal antibodies. Mol Cell Biochem 1984; 62(2): 109-20.
33. Traggiai E, Becker S, Subbarao K, et al. An efficient method to make human monoclonal antibodies from memory B cells: Potent neutralization of SARS coronavirus. Nat Med 2004; 10(8): 871-5.
34. Duvall M, Bradley N, Fiorini RN. A novel platform to produce human monoclonal antibodies: The next generation of therapeutic human monoclonal antibodies discovery. MAbs 2011; 3(2): 203-8.
35. Wiesner M, Zentz C, Mayr C, et al. Conditional immortalization of human B cells by CD40 ligation. PLoS One 2008; 3(1): E1464.
36. Kwakkenbos MJ, Diehl SA, Yasuda E, et al. Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat Med 2010; 16(1): 123-8.
37. Kumar A, Ta D, Henderson D, et al. bcl2 and v-abl oncogenes cooperate to immortalize murine B cells that secrete antigen specific antibodies. Immunol Lett 1999; 65(3): 153-9.
38. Liang X, Paden CR, Morales FM, Powers RP, Jacob J, Speck SH. Murine gamma-herpesvirus immortalization of fetal liver-derived B cells requires both the viral cyclin D homolog and latencyassociated nuclear antigen. PLoS Pathog 2011; 7(9): E1002220.
39. Sullivan M, Kaur K, Pauli N, Wilson PC. Harnessing the immune system's arsenal: Producing human monoclonal antibodies for therapeutics and investigating immune responses. F1000 Biol Rep 2011; 3: 17.
40. Cronin M, Ross JS. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology. Biomark Med 2011; 5(3): 293-305.
41. Loman NJ, Misra RV, Dallman TJ, et al. Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol 2012; 30(5): 434-9.
42. Benichou J, Ben-Hamo R, Louzoun Y, Efroni S. Rep-Seq: Uncovering the immunological repertoire through next-generation sequencing. Immunology 2012; 135(3): 183-91.
43. Arnaout R, Lee W, Cahill P, et al. High-resolution description of antibody heavy-chain repertoires in humans. PLoS One 2011; 6(8): E22365.
44. Briney BS, Willis JR, Hicar MD, Thomas JW, Crowe JE, Jr. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology 2012; 137(1): 56-64.
45. Fischer N. Sequencing antibody repertoires: The next generation. MAbs 2011; 3(1): 17-20.
46. Larimore K, McCormick MW, Robins HS, Greenberg PD. Shaping of Human Germline IgH Repertoires Revealed by Deep Sequencing. J Immunol 2012; 189(6): 3221-30.
47. Weinstein JA, Jiang N, White RA, III, Fisher DS, Quake SR. Highthroughput sequencing of the zebrafish antibody repertoire. Science 2009; 324(5928): 807-10.
48. Kohsaka H, Carson DA, Rassenti LZ, et al. The human immunoglobulin V(H) gene repertoire is genetically controlled and unaltered by chronic autoimmune stimulation. J Clin Invest 1996; 98(12): 2794-800.
49. Reddy ST, Ge X, Miklos AE, et al. Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat Biotechnol 2010; 28(9): 965-9.
50. Dohmen SE, Mulder A, Verhagen OJ, Eijsink C, Franke-van Dijk ME, van der Schoot CE. Production of recombinant Ig molecules from antigen-selected single B cells and restricted usage of Ig-gene segments by anti-D antibodies. J Immunol Methods 2005; 298(1-2): 9-20.
51. Derda R, Tang SK, Li SC, Ng S, Matochko W, Jafari MR. Diversity of phage-displayed libraries of peptides during panning and amplification. Molecules 2011; 16(2): 1776-803.
52. Matochko WL, Chu K, Jin B, Lee SW, Whitesides GM, Derda R. Deep sequencing analysis of phage libraries using Illumina platform. Methods 2012; %20. pii: S1046-2023(12): 10.
53. Ravn U, Gueneau F, Baerlocher L, et al. By-passing in vitro screening-next generation sequencing technologies applied to antibody display and in silico candidate selection. Nucleic Acids Res 2010; 38(21): E193.
54. Venet S, Ravn U, Buatois V, et al. Transferring the Characteristics of Naturally Occurring and Biased Antibody Repertoires to Human Antibody Libraries by Trapping CDRH3 Sequences. PLoS One 2012; 7(8): E43471.
55. Ravn U, Didelot G, Venet S, et al. Deep sequencing of phage display libraries to support antibody discovery. Methods 2013; 60(1): 99-110.